Two molecular pathways initiate mitochondria-dependent dopaminergic neurodegeneration in experimental Parkinson's disease.
Perier C, Bové J, Wu DC, Dehay B, Choi DK, Jackson-Lewis V, Rathke-Hartlieb S, Bouillet P, Strasser A, Schulz JB, Przedborski S, Vila M.
Perier C, et al. Among authors: vila m.
Proc Natl Acad Sci U S A. 2007 May 8;104(19):8161-6. doi: 10.1073/pnas.0609874104. Epub 2007 May 2.
Proc Natl Acad Sci U S A. 2007.
PMID: 17483459
Free PMC article.